SKI Market

Indian Indices

Nifty

24,971.90 -140.50
(-0.56%)

Sensex

82,642.35 745.56
( 0.91%)

Bank Nifty

56,059.35 -193.50
( -0.34%)

Nifty IT

38,414.10 -577.35
( -1.48%)

Global Indices

Nasdaq

42,601.30 373.47
(0.88%)

Dow Jones

6,045.90 57.06
(0.95%)

Hang Seng

38,777.68 423.59
(1.10%)

Nikkei 225

8,758.04 -16.61
(-0.19%)

Forex

USD-INR

86.50 -0.18
(-0.20%)

EUR-INR

99.61 0.16
(0.17%)

GBP-INR

116.27 -0.12
(-0.11%)

JPY-INR

0.59 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

30.5295026

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

58.05

10916.71

EPS(TTM)

Face Value()

Div & Yield %

4.15

0.33

Back

NCL Research and Financial Services Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication

Jun 02,2025

Please find attached Newspaper cuttings of publication of Audited Financial Results for March 2025

24,971.90 -140.50 (-0.56%)

82,642.35 745.56 ( 0.91%)

56,059.35 -193.50 ( -0.34%)

38,414.10 -577.35 ( -1.48%)

42,601.30 373.47 (0.88%)

6,045.90 57.06 (0.95%)

38,777.68 423.59 (1.10%)

8,758.04 -16.61 (-0.19%)

86.50 -0.18 (-0.20%)

99.61 0.16 (0.17%)

116.27 -0.12 (-0.11%)

0.59 0.00 (-0.73%)